Exact Mass: 322.026

Exact Mass Matches: 322.026

Found 70 metabolites which its exact mass value is equals to given mass value 322.026, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sulprofos

Ethoxy-(4-methylsulphanylphenoxy)-propylsulphanyl-sulphanylidene-$l^{5}-phosphane

C12H19O2PS3 (322.0285)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

digallate

Benzoic acid,3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]-

C14H10O9 (322.0325)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

Sulfotep

Diethoxy-[ethoxy(methoxymethyl)phosphinothioyl]oxy-sulfanylidene-lambda5-phosphane

C8H20O5P2S2 (322.0227)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Sulfotep

O,O-diethyl {[diethoxy(sulfanylidene)-λ⁵-phosphanyl]oxy}phosphonothioate

C8H20O5P2S2 (322.0227)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Trofosfamide

2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)-1,3,2lambda5-oxazaphosphinan-2-one

C9H18Cl3N2O2P (322.0171)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   

cyanidin

1-benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, chloride (1:1)

C15H11ClO6 (322.0244)


See also: Bilberry (part of). Cyanidin Chloride (IdB 1027), a subclass of anthocyanin, displays antioxidant and anti-carcinogenesis properties. Cyanidin Chloride (IdB 1027) inhibits osteoclast formation, hydroxyapatite resorption, and receptor activator of NF-κB ligand (RANKL)-induced osteoclast marker gene expression[1]. Cyanidin Chloride (IdB 1027), a subclass of anthocyanin, displays antioxidant and anti-carcinogenesis properties. Cyanidin Chloride (IdB 1027) inhibits osteoclast formation, hydroxyapatite resorption, and receptor activator of NF-κB ligand (RANKL)-induced osteoclast marker gene expression[1].

   
   

ClC(C(C=C(C=CC=CC=CC(CC)C)O)=O)(Cl)Cl

ClC(C(C=C(C=CC=CC=CC(CC)C)O)=O)(Cl)Cl

C14H17Cl3O2 (322.0294)


   

6-(Sulfooxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid 3-methyl ester

6-(Sulfooxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid 3-methyl ester

C13H10N2O6S (322.026)


   
   

2-CHLORO-N-(4-CHLORO-2-((HYDROXYIMINO)(PHENYL)METHYL)PHENYL)ACETAMIDE

2-CHLORO-N-(4-CHLORO-2-((HYDROXYIMINO)(PHENYL)METHYL)PHENYL)ACETAMIDE

C15H12Cl2N2O2 (322.0276)


   

methyl 4-(methylsulfonamidomethyl)-2-sulfamoylbenzoate

methyl 4-(methylsulfonamidomethyl)-2-sulfamoylbenzoate

C10H14N2O6S2 (322.0293)


   

5-bromo-2,2-diethoxy-4,5-bipyridine

5-bromo-2,2-diethoxy-4,5-bipyridine

C14H15BrN2O2 (322.0317)


   

Ethanone,1,1-(oxydi-4,1-phenylene)bis[2-chloro-

Ethanone,1,1-(oxydi-4,1-phenylene)bis[2-chloro-

C16H12Cl2O3 (322.0163)


   

5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene

5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene

C19H15Br (322.0357)


   

3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)ACRYLIC ACID

3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)ACRYLIC ACID

C16H12Cl2O3 (322.0163)


   

9-BROMO-11,11-DIMETHYL-11H-BENZO[A]FLUORENE

9-BROMO-11,11-DIMETHYL-11H-BENZO[A]FLUORENE

C19H15Br (322.0357)


   

3-(4-((3,4-DICHLOROBENZYL)OXY)PHENYL)ACRYLIC ACID

3-(4-((3,4-DICHLOROBENZYL)OXY)PHENYL)ACRYLIC ACID

C16H12Cl2O3 (322.0163)


   

methyl 3-[(4-bromo-3,5-dimethylpyrazol-1-yl)methyl]benzoate

methyl 3-[(4-bromo-3,5-dimethylpyrazol-1-yl)methyl]benzoate

C14H15BrN2O2 (322.0317)


   

4-chloro-2,5-diphenylthieno[2,3-d]pyrimidine

4-chloro-2,5-diphenylthieno[2,3-d]pyrimidine

C18H11ClN2S (322.0331)


   

N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMide

N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMide

C12H10N4O3S2 (322.0194)


   

1-(BENZYLOXY)-4-BROMO-2,5-DIMETHOXYBENZENE

1-(BENZYLOXY)-4-BROMO-2,5-DIMETHOXYBENZENE

C15H15BrO3 (322.0204)


   

3-chloro-2-(3-chloro-4-methoxyphenyl)-5-methoxyindazole

3-chloro-2-(3-chloro-4-methoxyphenyl)-5-methoxyindazole

C15H12Cl2N2O2 (322.0276)


   

N,N-bis(3-chlorophenyl)propanediamide

N,N-bis(3-chlorophenyl)propanediamide

C15H12Cl2N2O2 (322.0276)


   

robinetinidin chloride

robinetinidin chloride

C15H11ClO6 (322.0244)


   

2-(2-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

2-(2-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

C16H12BBrN2 (322.0277)


   

2-(3-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

2-(3-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

C16H12BBrN2 (322.0277)


   

2-(4-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

2-(4-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

C16H12BBrN2 (322.0277)


   

Carbazochrome sodium sulfonate (AC-17)

Carbazochrome sodium sulfonate (AC-17)

C10H11N4NaO5S (322.0348)


Carbazochrome sodium sulfonate (AC-17) is a capillary stabiliser and used for the research of haemorrhage. Carbazochrome sodium sulfonate is an antihemorrhagic agent[1].

   

4-iodo-1-[2-(oxan-2-yloxy)ethyl]pyrazole

4-iodo-1-[2-(oxan-2-yloxy)ethyl]pyrazole

C10H15IN2O2 (322.0178)


   

4-(3-NITRO-BENZENESULFONYLAMINO)-BENZOIC ACID

4-(3-NITRO-BENZENESULFONYLAMINO)-BENZOIC ACID

C13H10N2O6S (322.026)


   

sodium,2-hydroxybenzoate,[(E)-(3-hydroxy-1-methyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea

sodium,2-hydroxybenzoate,[(E)-(3-hydroxy-1-methyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea

C10H11N4NaO5S (322.0348)


   

Ethyl 1-benzyl-4-bromo-3-methyl-1H-pyrazole-5-carboxylate

Ethyl 1-benzyl-4-bromo-3-methyl-1H-pyrazole-5-carboxylate

C14H15BrN2O2 (322.0317)


   

Ethyl 1-benzyl-4-bromo-5-methyl-1H-pyrazole-3-carboxylate

Ethyl 1-benzyl-4-bromo-5-methyl-1H-pyrazole-3-carboxylate

C14H15BrN2O2 (322.0317)


   

ethyl 5-(4-bromophenyl)-1-ethylpyrazole-3-carboxylate

ethyl 5-(4-bromophenyl)-1-ethylpyrazole-3-carboxylate

C14H15BrN2O2 (322.0317)


   

2-Hydroxy-5-[(4-sulfophenyl)diazenyl]benzoic acid

2-Hydroxy-5-[(4-sulfophenyl)diazenyl]benzoic acid

C13H10N2O6S (322.026)


   

2-Bromo-11,11-dimethyl-11H-benzo[b]fluorene

2-Bromo-11,11-dimethyl-11H-benzo[b]fluorene

C19H15Br (322.0357)


   

tert-Butyl 3-(4-bromophenyl)-1H-pyrazole-1-carboxylate

tert-Butyl 3-(4-bromophenyl)-1H-pyrazole-1-carboxylate

C14H15BrN2O2 (322.0317)


   

4-Iodo-4-propylbiphenyl

4-Iodo-4-propylbiphenyl

C15H15I (322.0218)


   

bis(4-trifluoromethylphenyl)phosphine

bis(4-trifluoromethylphenyl)phosphine

C14H9F6P (322.0346)


   

Trityl Bromide

Trityl Bromide

C19H15Br (322.0357)


   

(5-BROMO-ISOQUINOLIN-1-YL)-CARBAMIC ACID TERT-BUTYL ESTER

(5-BROMO-ISOQUINOLIN-1-YL)-CARBAMIC ACID TERT-BUTYL ESTER

C14H15BrN2O2 (322.0317)


   

Arsine oxide,triphenyl-

Arsine oxide,triphenyl-

C18H15AsO (322.0339)


   

(5-Chloropyrazolo[1,5-A]pyrimidin-7-YL)-(4-methanesulfonylphenyl)amine

(5-Chloropyrazolo[1,5-A]pyrimidin-7-YL)-(4-methanesulfonylphenyl)amine

C13H11ClN4O2S (322.0291)


   

UMP dianion

UMP dianion

C9H11N2O9P-2 (322.0202)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-[1-(4-Chloro-phenyl)-ethyl]-4,6-dinitro-phenol

2-[1-(4-Chloro-phenyl)-ethyl]-4,6-dinitro-phenol

C14H11ClN2O5 (322.0356)


   

Trofosfamide

Trofosfamide

C9H18Cl3N2O2P (322.0171)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   

Tazobactam sodium

Tazobactam Sodium Salt

C10H11N4NaO5S (322.0348)


An organic sodium salt having tazobactam(1-) as the counterion; used in combination with ceftolozane sulfate for treatment of complicated intra-abdominal infections and complicated urinary tract infections. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor D004791 - Enzyme Inhibitors

   

digallate

3,4-dihydroxy-5-[oxo-(3,4,5-trihydroxyphenyl)methoxy]benzoic acid

C14H10O9 (322.0325)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

Gallic acid 3-O-gallate

Benzoic acid,3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]-

C14H10O9 (322.0325)


Digallic acid is a polyphenolic compound found in Pistacia lentiscus. Digallic acid is also present in the molecule of tannic acid. Digalloyl esters involve either -meta or -para depside bonds. [Wikipedia]

   

3-O-phosphonatouridine

3-O-phosphonatouridine

C9H11N2O9P-2 (322.0202)


   

Pseudouridine 5-phosphate(2-)

Pseudouridine 5-phosphate(2-)

C9H11N2O9P-2 (322.0202)


   

Uridine 2-phosphate(2-)

Uridine 2-phosphate(2-)

C9H11N2O9P-2 (322.0202)


   

Ribavirin-5-monophosphate

Ribavirin-5-monophosphate

C8H11N4O8P-2 (322.0314)


   

Arabinouracil 5-monophosphate

Arabinouracil 5-monophosphate

C9H11N2O9P-2 (322.0202)


   

5-(4-bromophenyl)-N,N-diethyl-3-isoxazolecarboxamide

5-(4-bromophenyl)-N,N-diethyl-3-isoxazolecarboxamide

C14H15BrN2O2 (322.0317)


   

2-[1-(p-Chlorophenyl)ethyl]-4,6-dinitrophenol

2-[1-(p-Chlorophenyl)ethyl]-4,6-dinitrophenol

C14H11ClN2O5 (322.0356)


   

Ribavirin 5-monophosphate(2-)

Ribavirin 5-monophosphate(2-)

C8H11N4O8P-2 (322.0314)


   

[1-[(3,4-Dichlorophenyl)methyl]-2-hydroxyindol-3-yl]-oxidoazanium

[1-[(3,4-Dichlorophenyl)methyl]-2-hydroxyindol-3-yl]-oxidoazanium

C15H12Cl2N2O2 (322.0276)


   

Merdafos

Sulprofos

C12H19O2PS3 (322.0285)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Digallic acid

Benzoic acid,3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]-

C14H10O9 (322.0325)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

uridine 5-monophosphate(2-)

uridine 5-monophosphate(2-)

C9H11N2O9P (322.0202)


A pyrimidine nucleoside 5-monophosphate(2-) that results from the removal of two protons from the phosphate group of UMP.

   

Ribavirin 5-monophosphate(2-)

Ribavirin 5-monophosphate(2-)

C8H11N4O8P (322.0314)


An organophosphate oxoanion resulting from the removal of both protons from the phosphate group of ribavirin 5-monophosphate. It is the major species at pH 7.3.

   

3-UMP(2-)

3-UMP(2-)

C9H11N2O9P (322.0202)


A nucleoside 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of uridine 3-monophosphate (UMP). It is the predominant species at physiological pH.

   

Pseudouridine 5-phosphate(2-)

Pseudouridine 5-phosphate(2-)

C9H11N2O9P (322.0202)


An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of pseudouridine 5-phosphate; major species at pH 7.3.

   

(3z,5e,7e,9e,11r)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

(3z,5e,7e,9e,11r)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

C14H17Cl3O2 (322.0294)


   

1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

C14H17Cl3O2 (322.0294)


   

3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)benzoic acid

3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)benzoic acid

C14H10O9 (322.0325)


   

(3z,5e,7e,9e)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

(3z,5e,7e,9e)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

C14H17Cl3O2 (322.0294)


   

3,4,5-trihydroxy-2-(3,4,5-trihydroxybenzoyl)benzoic acid

3,4,5-trihydroxy-2-(3,4,5-trihydroxybenzoyl)benzoic acid

C14H10O9 (322.0325)